News Archives - Page 7 of 1183 - BioHealth Innovation

News

January 31, 2025

Theradaptive’s OsteoAdapt™ SP Launches in Maryland with First Patient Dosed and $1 Million MSCRF Grant Support

FREDERICK, Md., Jan. 30, 2025 /PRNewswire-PRWeb/ -- Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for…

Andy

Love0

News

January 30, 2025

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing…

Andy

Love0

News

January 30, 2025

citybiz: ETC Baltimore Marks Milestone with Opening of Venture Hub at Connect Labs Baltimore

ETC Baltimore, dedicated to elevating Baltimore as a national leader in tech startups, announces the opening of its inaugural ETC Venture Hub at Connect…

Andy

Love0

News

January 29, 2025

Exciting Opportunities for BioHealth Companies in Montgomery County, MD in 2025 and Beyond

For the second year in a row, the BioHealth Capital Region (BHCR) has been ranked as a Top 3 BioCluster…

Andy

Love0

News

January 29, 2025

Kalocyte Selected to Join Blue Knight

BALTIMORE, January 28, 2025 – KaloCyte, Inc., a pre-clinical biotech startup company developing a bio-inspired red blood cell substitute called ErythroMer™, announced…

Andy

Love0

News

January 28, 2025

MIMETAS Launches OrganoPlate UniFlow Technology at SLAS 2025

LEIDEN, Netherlands, January 28, 2025 / Biotech Newswire / -- MIMETAS, a global leader in human disease modeling, has launched OrganoPlate…

Andy

Love0

News

January 28, 2025

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical…

Andy

Love0

News

January 27, 2025

TEDCO Invests in ReBokeh

COLUMBIA, Md., (January 27, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $100,000 investment in ReBokeh…

Andy

Love0

News

January 27, 2025

MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

BALTIMORE, Jan. 24, 2025 /PRNewswire/ -- In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights…

Andy

Love0

News

January 27, 2025

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis

FREDERICK, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

Theradaptive’s OsteoAdapt™ SP Launches in Maryland with First Patient Dosed and $1 Million MSCRF Grant Support

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

citybiz: ETC Baltimore Marks Milestone with Opening of Venture Hub at Connect Labs Baltimore

Exciting Opportunities for BioHealth Companies in Montgomery County, MD in 2025 and Beyond

Kalocyte Selected to Join Blue Knight

MIMETAS Launches OrganoPlate UniFlow Technology at SLAS 2025

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

TEDCO Invests in ReBokeh

MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search